NCT02950259 2025-12-03
Pre-operative IRX-2 in Early Stage Breast Cancer (ESBC)
Providence Health & Services
Phase 1 Completed
Providence Health & Services
Brigham and Women's Hospital
University of Southern California
Brooklyn ImmunoTherapeutics, LLC
CEL-SCI Corporation
University of Rochester
M.D. Anderson Cancer Center
New Mexico Cancer Research Alliance